share_log

Elite Pharmaceuticals Q3 EPS $(0.01), Sales $14.36M Down From $15.54M YoY

Benzinga ·  Feb 13 21:18

Elite Pharmaceuticals (OTC:ELTP) reported quarterly losses of $(0.01) per share. The company reported $14.36 million in sales this quarter. This is a 7.56 percent decrease over sales of $15.54 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 300

Recommended

Write a comment